Navigation Links
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Date:6/16/2008

these new approaches into clinical medicine."

"We are gratified for the opportunity to work jointly with Fox Chase Cancer Center and Olympus Corporation to develop the first clinical applications of our fluorescence molecular imaging technology platforms," said Kirtland Poss, President and CEO of VisEn Medical. "This program is a major step forward in VisEn Medical's central mission, which is to lead the development and commercialization of fluorescence in vivo imaging technologies in a range of translational applications from research through clinical medicine, enabling substantial benefits for researchers, pharmaceutical companies, doctors and patients."

Both Dr. Seiden and Mr. Poss noted the contributions to the project by Olympus Medical Systems Corp. "We are pleased to receive the system support from Olympus Medical Systems Corp. through their provision of these novel fluorescence imaging systems into the program," said Mr. Poss. "These advances will help open up new opportunities for more effective and efficient cancer detection, surgery and treatment."

The ProSense(R) Activatable Imaging Agent platform was developed to provide in vivo readouts of some of the key protease activities known to underlie disease states in oncology, inflammation, and cardiovascular disease. A pre-clinical version of ProSense is currently being used by leading academic institutions and pharmaceutical customers worldwide to image disease-related in vivo protease profiles in pre-clinical research and drug development. The IND program and the planned Phase I clinical trials are designed to translate the benefits of ProSense into humans, as well as to further develop the multi-channel white light and near infrared fluorescence laparoscopic imaging systems used in collecting and analyzing fused images in real time in the operating room. The planned trial is also designed to gather safety and imaging data for the agent, which will be administered systemically, and to
'/>"/>

SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
5. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
6. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
7. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 BioClinica®, Inc ., ein ... gab heute bekannt, dass es mit MediciGroup ® ... und Erhalt von Patienten übernommen hat. Der ... Ltd. und Access to Patients, LLC. Medici bietet ... Auffinden von Patienten, die für die Nachbeobachtung verloren ...
(Date:7/7/2015)... 7, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", ... and marketer of medical devices worldwide, announced today ... in Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio") ... is a domestic medical orthopedic-product provider that specializes ... Prior to today,s announcement, Mindray already has a ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, a ... and veterinary oncology, has filed a registration statement on ... connection with the proposed public offering of ordinary stock ... of American Depositary Shares, representing ordinary shares, to be ... not yet been determined. An Investor Roadshow will be ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
... COLORADO SPRINGS, Colo., Dec. 14, 2010 Cannabis Science, Inc. ... biotech company developing pharmaceutical cannabis products, is pleased to announce ... as its new base of operations in Denver, Colorado. The ... Unit H will be dedicated to housing executive offices, administrative ...
... 13, 2010 The board of directors of Pfizer Inc. ... 2011 dividend on the company,s common stock, payable March 1, ... on February 4, 2011.  Pfizer increased the dividend by approximately ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) "This dividend increase is ...
Cached Medicine Technology:Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 2Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 3Pfizer Declares A 20-Cent First-Quarter 2011 Dividend 2
(Date:7/7/2015)... ... 2015 , ... Today, the physicians at Allied Anesthesia, who provide services to ... Bernardino counties, released a series of tips to help children stay safe over the ... who spend more unsupervised time outdoors. , The most common causes of injuries ...
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a wearable startup ... first line of luxury smart jewelry called the Socialite™ collection. The product line ... fall. , “The Socialite collection was crafted to inspire women to be ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... growth strategy expert Jay Warden as Senior Vice President, heading the firm’s Healthcare ... to provide the best solutions to healthcare providers’ needs in ways that strengthen ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed ... stressful days at work is knowing that there is hopefully a vacation to look ... free as imagined. Planning for a vacation can be quite stressful, and it’s difficult ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3
... Ormond Street Hospital have developed a way of testing the ... known that very young children have a problem in breathing ... function tests. ,The researchers have devised a method ... of five years. The test was presented at the launch ...
... Seven women doctors have been suspended for their alleged ... sting operation beamed yesterday. // ,The doctors ... (Kota), Priyanaka Saxena (Sawaimadhopur), Madhu Mathur (Jhalawar), Rajkumar Choudhary ... on "awaiting posting order" and asked to report to ...
... Sun Pharmaceutical Industries Ltd today said it has allotted 61,716 ... into equity shares by FCCB holders. // ,The ... equity shares of Rs five each of the company at ... FCCBs of 1000 dollar each, the company informed the Bombay ...
... has revealed that only about 50% of the people are ... Mater Hospital in North Dublin. ,Nearly 4 among ... stance that the new hospital comes up at Mater. There ... wrong note, and now the opposition parties have requested the ...
... An analysis of records of pancreatic surgery during the ... by pancreatic cancer surgeon// Charles J. Yeo, M.D., Samuel ... Medical College of Thomas Jefferson University and Thomas Jefferson ... and his colleagues have revealed that contrary to what ...
... intestinal surgery, including stomach reduction for obesity, may increase ... of the study have been published in the British ... on three patients with increasingly poor eyesight or night ... space of a year. None of the patients had ...
Cached Medicine News:Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 3
Suture scissor...
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
...
Knife rasp for shoulder arthroscopy....
Medicine Products: